Study on HIV prevention for people who inject drugs
Part of Infections clinical trials.
This study tests different ways to help people who inject drugs stay on PrEP, a daily pill that prevents HIV. It's for people who are HIV-negative and have recently injected drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have injected drugs at least once in the past month.
- You have used a syringe service program (a place where you can get clean needles) in the past 30 days.
- You are willing to take part in multiple counseling sessions and follow-up visits.
- A doctor has said you might benefit from PrEP in the last 6 months (based on CDC guidelines).
- You are HIV-negative and not already taking PrEP.
- You do not have severe kidney problems or a chronic hepatitis B infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether telehealth support can help people who inject drugs start and stay on PrEP (HIV prevention medicine). You will join several sessions and follow-up visits to see if this approach works better than standard care.
This study looks at whether getting support from friends and peers who also use drugs can help people start HIV prevention (PrEP) and treatment for substance use. The goal is to make it easier for people who inject drugs to get the care they need.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
This study looks at how well a daily HIV prevention pill (F/TAF) works for people who use drugs. It also includes interviews with healthcare providers and peer navigators to understand how to better support patients.
This study tests a text-message program to help people who use drugs learn about and start taking PrEP, a daily pill that prevents HIV. The program sends short messages on your phone to support you in staying HIV-free.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.